Ipca Laboratories Ltd share price logo

Ipca Laboratories Ltd

NSE: IPCALAB

BSE: 524494

Mid Cap

Pharma Sector

₹1507.70

+17.30

(+1.16%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Rating Alert

Motilal Oswal maintains Buy rating on Ipca Laboratories with Rs 1730 target, citing strong FY27 revenue growth and margin expansion projections.

Ipca Laboratories Stock Performance

as on June 2, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,470.00
    ₹1,518.00
    downward going graph

    2.50%

    Downside

    0.68%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,251.60
    ₹1,678.30
    downward going graph

    16.99%

    Downside

    11.32%

    Upside

    downward going graph

Ipca Laboratories share price movements today

Previous Close
₹1,490.40
Open
₹1,510.00
Volume
3.83L
Upper Circuit
₹1,788.40
Lower Circuit
₹1,192.40
Day's Low - High
₹1,470.00 - ₹1,518.00
52 Week Low - High
₹1,251.60 - ₹1,678.30

Ipca Laboratories Historical Returns

1 Month Return
-2.59 %
3 Month Return
-1.49 %
1 Year Return
+ 5.27 %
3 Year Return
+ 108.68 %
5 Year Return
+ 43.33 %

Ipca Laboratories Fundamentals

as on June 2, 2026 at 4:01 pm IST

Market Cap

₹37,812.08 Cr

Return on Equity (ROE)

12.39

PE Ratio (TTM)

32.05

Return on capital employed (ROCE)

17.21

Industry PE ratio

45.43

Beta (LTM)

0.04

P/B Ratio

5.53

Dividend Yield

0.27

PEG Ratio

1.84

Quarterly Earnings Growth YOY

370.36

EPS (TTM)

31.04

Book Value

273.88

Ipca Laboratories Stock Valuation

as on June 2, 2026 at 4:01 pm IST

Ipca Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (18.72x)

October 10, 2019

Today (32.05x)

June 1, 2026

Industry (45.43x)

June 1, 2026

Highest (65.89x)

September 25, 2024

LowHigh

Today’s Price to Earnings Ratio: 32.05x

Ipca Laboratories Technical Analysis

Track how Ipca Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish12
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
2.02
Bearish
CCI (20)
-186.66
Bullish
RSI (14)
59.75
Neutral
Momentum (10)
1.3
Bearish
ADI (14)
25.48
Bullish
Ultimate Oscillator (7,14,28)
75.48
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1509.95
Bullish
EMA (20)
1510.22
Bullish
VWMA (20)
1511.4
Bullish
SMA (50)
1506.32
Bullish
EMA (50)
1507
Bullish
SMA (200)
1496.72
Bullish
EMA (200)
1499.6
Bullish
KAMA (200)
1507.19
Bullish
DEMA (200)
1504.76
Bullish

Ipca Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ipca Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ipca Laboratories Ltd image
Ipca Laboratories Ltd
BUY37,812.088.67%0.657878,939
Sanofi India Ltd image
Sanofi India Ltd
BUY7,179.83-11.99%0.004132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY83,269.539.67%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD1,09,800.2514.78%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY57,035.0013.57%0.001,4146,445
See all

Market expectation of Ipca Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Ipca Laboratories Stock’s Investor Sentiment and Interest

Investment in Ipca Laboratories Ltd Shares on INDmoney has grown by 96.55% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:96.55% versus previous 30 day period

Search interest for Ipca Laboratories Ltd Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:3% versus previous 30 day period

Ipca Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
1,585.21
2,033.96
2,052.85
2,033.03
2,092.63
2,354.9
2,245.37
2,246.69
2,308.85
2,556.5
2,392.5
2,388.48
Other Income
44.85
38.55
90.91
18.92
20.61
26.26
20.11
25.82
32.66
27.86
37.84
93.74
Total Income
1,630.06
2,072.51
2,143.76
2,051.95
2,113.24
2,381.16
2,265.48
2,272.51
2,341.51
2,584.36
2,430.34
2,482.22
Expenses
1,277.59
1,712.69
1,721.97
1,847.85
1,699.91
1,913.42
1,782.29
2,022.88
1,892.43
2,069.84
1,859.15
1,950.43
Operating Profit
307.62
321.27
330.88
185.18
392.72
441.48
463.08
223.81
416.42
486.66
533.35
438.05
Operating Profit Margin %
19.41%
15.8%
16.12%
9.11%
18.77%
18.75%
20.62%
9.96%
18.04%
19.04%
22.29%
18.34%
Profit Before Interest, Tax and Depreciation
352.47
359.82
421.79
204.1
413.33
467.74
483.19
249.63
449.08
514.52
571.19
531.79
Interest
31.38
44.12
33.4
29.37
24.05
22.56
16.81
21.51
18.51
19.61
17.62
20.2
Depreciation
69.27
90.34
99.5
98.13
98.89
100.35
98.46
100.12
100.06
103.33
107.59
107.14
Profit Before Tax
251.82
225.36
288.89
76.6
290.39
344.83
367.92
128
330.51
391.58
445.98
404.45
Tax Paid
85.61
87.92
66.24
73.69
91.41
99.39
90.59
62.22
96.09
108.08
81.93
95.05
Profit After Tax
166.21
137.44
222.65
2.91
198.98
245.44
277.33
65.78
234.42
283.5
364.05
309.4
Total Net profit including share of profit / Loss from associate company
164.1
136.49
221
1.33
199.14
245.75
276.36
63.99
232.89
280.53
363.67
306.69
EPS
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
13.31
Actual EPS
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
13.31
Adjusted EPS
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
13.31
Diluted EPS
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
11.79

Ipca Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
3,283.57
3,773.18
4,648.71
5,419.99
5,829.79
6,244.32
7,705.04
8,939.59
9,646.33
Other Income
41.8
57.68
67
62.84
66.57
125.62
124.77
92.8
174.45
Total Income
3,325.37
3,830.86
4,715.71
5,482.83
5,896.36
6,369.94
7,829.81
9,032.39
9,820.78
Expenses
2,833.09
3,083.11
3,749.82
3,875.64
4,520.53
5,317.55
6,491.63
7,418.5
7,754.2
Operating Profit
450.48
690.07
898.89
1,544.35
1,309.26
926.77
1,213.41
1,521.09
1,892.13
Operating Profit Margin %
13.72%
18.29%
19.34%
28.49%
22.46%
14.84%
15.75%
17.02%
19.62%
Profit Before Interest, Tax and Depreciation
492.28
747.75
965.89
1,607.19
1,375.83
1,052.39
1,338.18
1,613.89
2,066.58
Interest
24.02
18.87
16.5
9.04
7.69
45.54
138.27
84.93
75.94
Depreciation
177.73
182.42
210.5
209.17
232.42
261.56
357.24
397.82
418.12
Profit Before Tax
290.53
546.46
738.89
1,388.98
1,135.72
745.29
842.67
1,131.14
1,572.52
Tax Paid
51.11
104.24
135.33
240.14
224.77
253.36
313.46
343.61
381.15
Profit After Tax
239.42
442.22
603.56
1,148.84
910.95
491.93
529.21
787.53
1,191.37
Total Net profit including share of profit / Loss from associate company
239.42
442.22
603.56
1,141.14
889.79
478.99
522.92
785.24
1,183.78
EPS
18.97
35.01
47.77
90.02
34.85
18.58
21.57
29.08
46.94
Actual EPS
18.97
35.01
47.77
90.02
34.85
18.58
21.57
29.08
46.94
Adjusted EPS
9.49
17.51
23.89
45.01
34.85
18.58
21.57
29.08
46.94
Diluted EPS
18.97
35.01
47.73
90.02
34.85
18.58
21.57
29.08
44.98

Ipca Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
708.65
281.91
341.13
501.03
570.35
1,090.13
856.07
805.81
944.65
1,321.32
Cash Flow from Investing Activities
-223.69
-145.42
-135.4
-179.92
-509.34
-520.69
-850.93
-725
-1,215.29
-869.5
Cash Flow from Financing Activities
-456.51
-154.13
-125.41
-183.2
-136.54
-305.82
426.78
507.24
-552.55
-282.98
Net Cash Flow
28.81
-26.04
75.32
152.77
-75.53
263.62
431.92
588.05
-823.19
168.84

Ipca Laboratories Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
46.29%
46.29%
46.3%
46.3%
46.3%
44.72%
44.72%
44.72%
44.72%
44.72%
44.72%
DII
35.05%
33.79%
34.37%
33.78%
34.23%
35.68%
36.06%
36.2%
36.77%
37.32%
37.45%
FII
9.86%
0%
10.51%
10.85%
10.83%
11.07%
10.76%
10.67%
10.43%
10.63%
10.63%
Public
8.81%
8.92%
8.82%
9.06%
8.64%
8.53%
8.46%
8.41%
8.07%
7.33%
7.2%
Total Outstanding Shares
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
Total Shareholders
95,930
82,809
81,165
84,753
82,975
90,189
88,306
85,582
82,870
77,673
82,184

Mutual Funds that own Ipca Laboratories Stock

Check out the Mutual Funds with significant holdings in Ipca Laboratories.

Ipca Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Ipca Laboratories.

  • Ipca Laboratories Ltd Earnings Results

    Ipca Laboratories Ltd’s net profit jumped 340.98% since last year same period to ₹299.07Cr in the Q4 2025-2026. On a quarterly growth basis, Ipca Laboratories Ltd has generated -8.34% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Ipca Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Ipca Laboratories Ltd has declared dividend of ₹2.00 per share on 29 May 2025 - translating a dividend yield of 0.40%.

    Read More about Dividends

Indices Featuring Ipca Laboratories Stock

Check stock indices that include Ipca Laboratories.

Nifty Healthcare

₹15,188.20

-0.52 (▲79.00%)

BSE Healthcare

₹46,285.06

-0.38 (▲178.42%)

Nifty Midcap 150

₹22,305.85

0.18 (▲40.65%)

Nifty LargeMidcap 250

₹16,167.70

0.29 (▲46.50%)

S&P BSE 250 LargeMidCap

₹10,444.87

0.42 (▲43.44%)

BSE 500

₹35,227.64

0.43 (▲150.02%)

Nifty MidSmallcap 400

₹20,336.90

0.30 (▲60.75%)

NIFTY PHARMA

₹24,006.30

-0.86 (▲207.95%)

S&P BSE 150 MidCap

₹16,306.17

0.33 (▲54.16%)

Nifty 500

₹22,521.10

0.37 (▲83.15%)

S&P BSE 400 MidSmallCap

₹12,128.77

0.39 (▲47.15%)

Insights on Ipca Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 30.52% to 31.24% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.43K Cr → 2.48K Cr (in ₹), with an average increase of 2.1% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.72% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.1% return, outperforming this stock by 33.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 144.8% return, outperforming this stock by 36.1%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 10.63% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IPCALAB stock has moved down by -5.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 326.27 Cr → 299.07 Cr (in ₹), with an average decrease of 8.3% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.33% to 7.20% in Mar 2026 quarter

About Ipca Laboratories Ltd

Ipca Laboratories is a fully integrated global pharmaceutical company, manufacturing and marketing over 350 formulations and 80 APIs in over 100 countries around the world. Established in 1949, with its original name as Indian Pharmaceutical Combine Association Limited, Ipca has 17 manufacturing units in India, producing APIs and Formulations that are approved by major drug regulatory authorities, including the US FDA, UK MHRA, South African MCC, Brazilian ANVISA and Australian TGA. Apart from native India, Ipca is also a recognized supplier of intermediates and APIs⁠—Atenolol, Chloroquine Phosphate, Furosemide, and Pyrantel Salts⁠—globally. Ipca has received accreditation from ISO 9001, Forbes Global 200 best small companies, WHOGMP, INVIMA Colombian, and German standards, making it a respected name in the pharmaceutical industry. Recently, Ipca has acquired a number of companies, namely Krebs Biochemicals and Industries Ltd., Pisgah Labs Inc., Trophic Wellness Private Ltd, Lyka Labs Limited, and M/s. Ramdev Chemical Private Limited, to further extend its presence in the global market.

Revenue: ₹2,388.48Cr as on March 2026 (Q4 FY26)
Net Profit: ₹309.40Cr as on March 2026 (Q4 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
OrganisationIpca Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPremchand Godha
E-voting on sharesClick here to vote

FAQs

What is Ipca Laboratories share price today?

Ipca Laboratories share price today stands at ₹1507.7 as on at the close of the market. Ipca Laboratories share today touched a day high of ₹1518 and a low of ₹1470.

What is the 52 week high and 52 week low range for Ipca Laboratories share?

Ipca Laboratories touched a 52 week high of ₹1678.3 and a 52 week low of ₹1251.6. Ipca Laboratories share price today i.e. is closed at ₹1507.7, which is -10.17% down from its 52 week high and 20.46% up from its 52 week low.

What is Ipca Laboratories's market capitalisation today?

Ipca Laboratories market capitalisation is ₹37,812.08 Cr as on .

How to buy Ipca Laboratories shares?

To buy Ipca Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for IPCALAB or Ipca Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ipca Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ipca Laboratories trading volume today?

Ipca Laboratories trading volume is 3.83L as on . This means that 3.83L shares of Ipca Laboratories were bought and sold on the stock market during today's trading session.